These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2783882)

  • 1. Advances in folate chemotherapy: status of 5-fluorouracil/leucovorin in advanced malignancies. August 3, 1988, Cleveland, Ohio. Proceedings.
    Cancer; 1989 Mar; 63(6 Suppl):995-1053. PubMed ID: 2783882
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of antifolates and folates on the antineoplastic action of fluoropyrimidines].
    Graczyk J
    Postepy Hig Med Dosw; 1992; 46(2):143-58. PubMed ID: 1470578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methotrexate and 5-fluorouracil with leucovorin therapy in advanced gastric cancer: the enhancement of 5-fluorouracil antitumor activity by leucovorin].
    Sugiura I; Ogasawara T; Kinoshita T; Ono Y; Onizuka T; Nagata K; Kamiya O; Ohara K; Hoshino A
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1938-40. PubMed ID: 3496053
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of leucovorin on the therapeutic index of fluorouracil in cancer patients.
    DeLap RJ
    Yale J Biol Med; 1988; 61(1):23-34. PubMed ID: 3284210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil/leucovorin study update.
    Erlichman C
    J Clin Oncol; 1991 Nov; 9(11):2076. PubMed ID: 1941066
    [No Abstract]   [Full Text] [Related]  

  • 6. [Combination of levofolinate calcium and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):315-22. PubMed ID: 10700909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cisplatin, 5-fluorouracil and leucovorin combination chemotherapy-added radiation therapy for advanced esophageal cancer--a case report].
    Hokita S; Fukura K; Imamura H; Kimura S; Toyoyama H; Hamahata H; Nakai H; Imakiire K; Okubo K; Miyaji K
    Gan To Kagaku Ryoho; 1995 Feb; 22(3):399-402. PubMed ID: 7880112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-FU/leucovorin: biochemical modulation that works?
    Arbuck SG
    Oncology (Williston Park); 1987 Apr; 1(2):61-74. PubMed ID: 3079477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leucovorin.5-FU therapy for advanced gastric cancer as a neoadjuvant chemotherapy].
    Kitamura M; Arai K; Iwasaki Y; Sasaki T; Maeda Y; Kobayashi T
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2115-7. PubMed ID: 8607625
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer chemotherapy in the future. Discussion].
    Akaza H; Sasaki T; Konishi T; Tsukuda M
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1422-33. PubMed ID: 14594003
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorouracil and leucovorin: there is a choice.
    Petrelli N; Rustum YM
    J Clin Oncol; 1993 Jul; 11(7):1434; author reply 1435. PubMed ID: 8315443
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of intra-arterial high-dose leucovorin and 5-FU including combination chemotherapy].
    Mitsuhata N; Matsuda T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3287-90. PubMed ID: 3490831
    [No Abstract]   [Full Text] [Related]  

  • 16. Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy.
    Bruckner HW; Spigelman M
    Mt Sinai J Med; 1988 Oct; 55(5):390-4. PubMed ID: 3265179
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of preoperative FPL (5-fluorouracil, cisplatin, leucovorin) therapy on patients with primary unresectable advanced gastric cancer].
    Tsujinaka T; Kato T; Shiozaki H; Murata A; Nishijima J; Kobayashi K; Inoue M; Miyata M; Kido Y; Mori T
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):303-6. PubMed ID: 8434971
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
    Burch PA; Block M; Schroeder G; Kugler JW; Sargent DJ; Braich TA; Mailliard JA; Michalak JC; Hatfield AK; Wright K; Kuross SA
    Clin Cancer Res; 2000 Sep; 6(9):3486-92. PubMed ID: 10999733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study.
    Colucci G
    Cancer; 1996 Mar; 77(5):1002-3. PubMed ID: 8608464
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma.
    Schwarz LR
    Cancer; 1996 Aug; 78(3):566-7. PubMed ID: 8697406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.